Browse > Article
http://dx.doi.org/10.14776/piv.2022.29.e8

Obesity Is a Related Factor With Severe COVID-19 Pneumonia in Children: A Case Series  

Kim, Dong Joon (Gyeongsang Institute of Health Sciences, Department of Pediatrics, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine)
Song, EunHyang (Department of Neurology, SeoBuk Seoul Metropolitan Hospital)
Jeon, Kyung Nyeo (Department of Radiology, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine)
Park, Su Eun (Department of Pediatrics, Pusan National University School of Medicine)
Seo, Ji-Hyun (Gyeongsang Institute of Health Sciences, Department of Pediatrics, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine)
Publication Information
Pediatric Infection and Vaccine / v.29, no.2, 2022 , pp. 77-83 More about this Journal
Abstract
A small proportion of children with coronavirus disease 2019 (COVID-19) develop severe pneumonia. We reported the severe COVID-19 pneumonia in children aged <18 years with COVID-19 treated with remdesivir and dexamethasone from August 2021 to November 2021 by a retrospective review of their medical records. Eight children were included (5 males and 3 females). Their median age was 16 years (range: 9 to 17 years) and their median body mass index was 30.5 kg/m2 (range: 22.8-38.5 kg/m2). All patients had fever and dyspnea with hypoxia. Chest radiographic findings were variable and included diffuse or multifocal consolidation, nodules, and ground-glass opacities in the lungs. After receiving intravenous remdesivir and dexamethasone, 7 of the 8 children experienced an improvement in their symptoms within 2 days. In our case series, obesity was present in 6 out of 8 children with severe COVID-19 pneumonia.
Keywords
COVID-19; Pneumonia; Child; Obesity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sun D, Li H, Lu XX, Xiao H, Ren J, Zhang FR, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study. World J Pediatr 2020;16:251-9.   DOI
2 Staceviciene I, Burokiene S, Steponaviciene A, Vaiciuniene D, Jankauskiene A. A cross-sectional study of screening for coronavirus disease 2019 (COVID-19) at the pediatric emergency department in Vilnius during the first wave of the pandemic. Eur J Pediatr 2021;180:2137-45.   DOI
3 National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines [Internet]. Bethesda: National Institutes of Health; 2021 [cited 2021 Dec 27]. Available from: https://www.covid19treatmentguidelines.nih.gov/.
4 GISAID. VOC Delta: country submission count [Internet]. Munich: GISAID; 2021 [cited 2022 Apr 18]. Available from: https://www.gisaid.org/hcov19-variants/.
5 Medical World News. On October 2, 3,213 variant viruses confirmed in the last week [Internet]. Seoul: Medical World News; 2022 [cited 2021 Oct 6]. Available from: medicalworldnews.co.kr/m/view.php?idx=1510945263.
6 Wang L, Li G, Yuan C, Yang Y, Ling G, Zheng J, et al. Progress in the diagnosis and treatment of COVID-19 in children: a review. Int J Gen Med 2021;14:8097-108.   DOI
7 Bixler D, Miller AD, Mattison CP, Taylor B, Komatsu K, Peterson Pompa X, et al. SARS-CoV-2-associted deaths among persons aged. MMWR Morb Mortal Wkly Rep 2020;69:1324-9.   DOI
8 Jo YH, Hwang Y, Choi SH. A case report for severe COVID-19 in a 9-year-old child treated with remdesivir and dexamethasone. J Korean Med Sci 2021;36:e203.   DOI
9 Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, et al. Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization. Ann Intern Med 2020;173:773-81.   DOI
10 McGowan RJ, Cennimo DJ. Coronavirus disease 2019 (COVID-19) in children [Internet]. New York: Medscape; 2021 [cited 2022 Jul 14]. Available from: https://emedicine.medscape.com/article/2500132-overview.
11 Cai X, Jiang H, Zhang S, Xia S, Du W, Ma Y, et al. Clinical manifestations and pathogen characteristics in children admitted for suspected COVID-19. Front Med 2020;14:776-85.   DOI
12 Qi K, Zeng W, Ye M, Zheng L, Song C, Hu S, et al. Clinical, laboratory, and imaging features of pediatric COVID-19: a systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25230.   DOI
13 Palabiyik F, Kokurcan SO, Hatipoglu N, Cebeci SO, Inci E. Imaging of COVID-19 pneumonia in children. Br J Radiol 2020;93:20200647.   DOI
14 Parisi GF, Indolfi C, Decimo F, Leonardi S, Miraglia Del Giudice M. COVID-19 pneumonia in children: from etiology to management. Front Pediatr 2020;8:616622.   DOI
15 Gotzinger F, Santiago-Garcia B, Noguera-Julian A, Lanaspa M, Lancella L, Calo Carducci FI, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health 2020;4:653-61.   DOI
16 Rye BY, Oh JY, Shin MJ, Kim SH, Kim IH. Global trends and characteristics of the SARS-CoV2 Delta variant. Public Health Wkly Rep 2021;14:2354-65.
17 Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open 2021;4:e2111182.   DOI
18 Kornitzer J, Johnson J, Yang M, Pecor KW, Cohen N, Jiang C, et al. A systematic review of characteristics associated with COVID-19 in children with typical presentation and with multisystem inflammatory syndrome. Int J Environ Res Public Health 2021;18:8269.   DOI
19 Foust AM, McAdam AJ, Chu WC, Garcia-Pena P, Phillips GS, Plut D, et al. Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID-19. Pediatr Pulmonol 2020;55:2213-24.   DOI
20 Liu L, She J, Bai Y, Liu W. SARS-CoV-2 infection: differences in hematological parameters between adults and children. Int J Gen Med 2021;14:3035-47.   DOI